A novel Caenorhabditis elegans allele, smn-1(cb131), mimicking a mild form of spinal muscular atrophy, provides a convenient drug screening platform highlighting new and pre-approved compounds

James N. Sleigh, Steven D. Buckingham, Behrooz Esmaeili, Mohan Viswanathan, Edwin Cuppen, Bethany M. Westlund, David B. Sattelle

    Research output: Contribution to journalArticlepeer-review

    Fingerprint

    Dive into the research topics of 'A novel Caenorhabditis elegans allele, smn-1(cb131), mimicking a mild form of spinal muscular atrophy, provides a convenient drug screening platform highlighting new and pre-approved compounds'. Together they form a unique fingerprint.

    Biochemistry, Genetics and Molecular Biology

    Neuroscience